ClinicalTrials.gg
CompletedNCT06653647Updated Dec 10, 2025

Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain

An interventional study of Guided Imagery Therapy in Functional Abdominal Pain Disorders, Irritable Bowel Syndrome (IBS) and Functional Gastrointestinal Disorders, sponsored by Baylor College of Medicine. Completed at 1 site in United States. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-12-10.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 344 studies in Irritable Bowel Syndrome with a site in United States — 45 open to participants now, 49 under way, 3 of them phase 3. Irritable Bowel Syndrome · United States.

Enrollment
273rd of 287
4 · median 61
Started
2025
with 15 others
No phase
134 of 344
21 open now
Registered
309th of 344
by date
Lead sponsor
9 of 344
Baylor College of Medicine

Among the 344 studies in Irritable Bowel Syndrome with a site in United States, this one is the 273rd largest by enrollment of the 287 interventional ones that give a count, is one of 16 that started in 2025, is one of 134 with no phase, and was the 309th registered.

Irritable Bowel Syndrome

1,121 studies on the registry are indexed under Irritable Bowel Syndrome; 212 are open to participants now.

Browse Irritable Bowel Syndrome studies →

Open to participants now

45 of the 344 studies in Irritable Bowel Syndrome with a site in United States are open now. Recruiting first, the newest first:

40 more — sign in →

All 45 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 131 Irritable Bowel Syndrome studies recruiting now, 35 (27%) set no upper age limit and 86 (66%) stop at 75 or younger; 19 take children under 18; 29 take healthy volunteers.

This study: 7 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 344 studies in Irritable Bowel Syndrome with a site in United States, or all of them as a file.
02

Study summary

Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet.

Participants will complete a baseline abdominal pain and stooling diary to determine eligibility and other surveys. Participants who qualify will be placed in one of two groups by chance:

  • Immediate Treatment Group
  • Delayed Treatment Group

After randomization, the Immediate Treatment Group will get immediate access to the guided imagery therapy (GIT) mobile app intervention. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out 7 days weekly for 8 weeks in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary and other psychometric surveys at the end of this intervention period.

After randomization, the Delayed Treatment group will be observed as they wait 8 weeks without app access. During this phase, these participants will continue to treat their abdominal pain in their usual fashion. After the end of this waiting period, participants will complete another abdominal pain and stooling diary and psychometric surveys again before gaining access to the GIT mobile app intervention. As noted previously, the mobile app intervention will ask participants to listen to a 10- to 15-minute GIT session 5 out of 7 days weekly for 8 weeks in addition to their usual care for their abdominal pain. Another abdominal pain and stooling diary and other psychometric surveys will be collected at the end of this app intervention.

Read the detailed description

After fully disclosing the study design, intervention options, randomization scheme, and potential side effects of the interventions, caregivers and their children will document their respective informed consent and assent electronically. REDCap is a secure web application designed for surveys and databases. All data captured through REDCap will be encrypted and transmitted securely to HIPAA-compliant institutional servers for storage.

Participants and their caregivers will complete the following surveys at baseline, second baseline phase (delayed treatment group only 8 weeks after baseline), and immediately post-therapy (delayed treatment group 16 weeks after baseline and immediate treatment group 8 weeks after baseline) through REDCap:

  • 2-week Abdominal Pain and Stooling Diary
  • Children's Somatic Symptoms Inventory (child self-report and parent proxy-report)
  • Pain Catastrophizing Scale - Child Version
  • Pain Catastrophizing Scale - Parent Version
  • Pediatric Quality of Life Inventory 4.0 Generic Core (child self-report and parent proxy-report)
  • Behavior Assessment System for Children 3rd Ed (child self-report and parent proxy-report)
03

Conditions studied

  • Functional Abdominal Pain Disorders
  • Irritable Bowel Syndrome (IBS)
  • Functional Gastrointestinal Disorders
  • Functional Colonic Disease
  • Gastrointestinal Disease
  • Digestive System Diseases
  • Neurological Manifestations
  • Signs and Symptoms, Digestive
  • Pain
  • Abdominal Pain/ Discomfort

Keywords

  • abdominal pain
  • irritable bowel syndrome
  • recurrent abdominal pain
04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Study staff will enroll children with functional abdominal pain disorders and their primary caregiver for this study.

Inclusion criteria

Inclusion Criteria:

  • Texas Children's Pediatrics patients 7 to 12 years old at enrollment
  • A Rome IV Functional Abdominal Pain Disorder as defined by a 2-week abdominal pain and stooling diary
  • Both children and their primary caregivers must be able to read and communicate in English proficiently to understand the intervention's audio therapy sessions and psychometric instruments.

Exclusion criteria

Exclusion Criteria:

  • Prior participation in principal investigator's related feasibility or usability study
  • Previous abdominal surgeries
  • Co-morbid conditions associated with abdominal pain (e.g., cystic fibrosis)
  • Autism
  • Significant development delay
  • Psychosis
  • Prior experience with cognitive behavioral therapy or guided imagery therapy to treat chronic abdominal pain
  • Alarm symptoms that warrant further medical evaluation (e.g., blood in stool)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Active comparator
    Immediate Treatment

    Participants randomized to the Immediate Treatment arm will receive immediate access to the guided imagery therapy mobile application intervention.

    Behavioral: Guided Imagery Therapy

  • Other
    Delayed Treatment

    Participants randomized to the Delayed Treatment arm will be placed on waitlist status and will not have any intervention from weeks 3 to 10. Participants will continue their usual care for their abdominal pain during this time. Then, this study arm will cross over to the guided imagery therapy mobile application intervention from weeks 11 to 18.

    Behavioral: Guided Imagery Therapy

Interventions

  • BehavioralGuided Imagery Therapy

    Participants will be asked to listen to a pre-recorded, 10 to 15 minute guided imagery therapy (GIT) session via mobile application 5 out of 7 days per week for 8 weeks in addition to their usual care for their abdominal pain.

06

What researchers measure

Primary outcomes

  1. Abdominal Pain Frequency

    Average number of abdominal pain episodes per day from a self-report 2-week abdominal pain diary

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

Secondary outcomes

  1. Abdominal Pain Intensity

    Average daily abdominal pain severity measured on a 0-10 (10 is most severe) ordinal scale from a self-report 2-week abdominal pain diary

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  2. Anxiety

    Behavior Assessment System for Children, third edition, child self-report Anxiety Scale, t score ranges from 20 to 120, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  3. Anxiety

    Behavior Assessment System for Children, third edition, parent proxy-report Anxiety Scale, t score ranges from 20 to 120, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  4. Depression

    Behavior Assessment System for Children, third edition, child self-report Depression scale, t score ranges from 20 to 120, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  5. Depression

    Behavior Assessment System for Children, third edition, parent-proxy report Depression scale, t scores ranges from 20 to 120, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  6. Somatization

    Children's Somatic Symptoms Inventory child self-report, raw score ranges from 0 to 96, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  7. Somatization

    Children's Somatic Symptoms Inventory parent-proxy report, raw score ranges from 0 to 96, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  8. Pain Catastrophizing Thoughts

    Pain Catastrophizing Scale - Child Version, raw score ranges from 0 to 52, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  9. Pain Catastrophizing Thoughts

    Pain Catastrophizing Scale - Parent Version, raw score range from 0 to 52, higher scores are worse

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  10. Health-Related Quality of Life

    Pediatric Quality of Life Inventory Generic Core Scales 4.0 child self-report, raw score ranges from 0 to 100, higher scores are better

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

  11. Health-Related Quality of Life

    Pediatric Quality of Life Inventory Generic Core Scales 4.0 parent-proxy report, raw score ranges from 0 to 100, higher scores are better

    Time frame: Baseline (both groups), Second baseline (delayed treatment group only, 8 weeks after baseline), and Post-intervention (delayed group 16 weeks after initial baseline, immediate group 8 weeks after baseline)

07

Study locations

1 site
  • Baylor College of Medicine / Texas Children's Hospital
    Houston, Texas 77030, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Nov 2025, 4 months.

Of 308 non-industry interventional studies with no phase under Irritable Bowel Syndrome, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 40. This study's 4 months is below that.

Counting every sponsor, half of 360 studies reached it within 19 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2024
First posted
Oct 22, 2024
StartActual
Jul 18, 2025
Primary completionActual
Nov 30, 2025
CompletionActual
Nov 30, 2025
Last update
Dec 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06653647
Responsible party
John M Hollier (Assistant Professor, Baylor College of Medicine) — Principal investigator
First posted
Oct 22, 2024
Start date
Jul 18, 2025
Primary completion
Nov 30, 2025
Completion
Nov 30, 2025
Last update
Dec 10, 2025

Study contacts

John M Hollier, MD, MS, MPH
principal investigator · Baylor College of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion